“ADVANTAGES OF USING LIPOSOME-ENCAPSULATED ANTIBIOTICS TO FIGHT INFECTIONS CAUSED BY ENTEROBACTERIA”, J Popl Ther Clin Pharmacol, vol. 31, no. 9, pp. 731–740, Sep. 2024, doi: 10.53555/nhwgvd87.